omniture
logo
Search
Insilico Medicine
Media Room

Latest News

rss

Insilico Medicine Reports Positive Phase IIa Results for ISM001-055, a Novel First-in-Class Drug Treatment for Idiopathic Pulmonary Fibrosis (IPF) Designed Using Generative AI

* ISM001-055 is a novel drug designed in-house using generative AI to target TNIK (Traf2- and NCK...

2024-09-18 21:30 706

AI for Good: Insilico Medicine Hosts IMGAIA Product Launch Event

Announcing Sustainability Benchmarking Initiative and New Gen-AI Features of Pharma.AI Platform CA...

2024-07-24 21:00 1356
AI for Good: Insilico Medicine Hosts IMGAIA Product Launch Event